REG - Mast Energy Dvlpmts. - Approval & Publication of Prospectus

Mast Energy DevelopmentsAnnouncement

09/07/2025 11:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250709:nRSI3888Qa&default-theme=true

RNS Number : 3888Q  Mast Energy Developments PLC  09 July 2025

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

LEI :213800HFVHGJ9YGO9F71

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

('MED' or 'the Company')

 

9 July 2025

 

Mast Energy Developments PLC

 

Approval and Publication of Prospectus

 

Mast Energy Developments PLC ("MED" or "the Company") the UK-based
multi-asset owner, developer, and operator in the rapidly growing Flexible
Generation Power market, is pleased to announce that further to its RNS
announcements dated 23 May 2025 and most recently 8 July 2025, that the
Financial Conduct Authority ("FCA") has today approved its Prospectus.

 

The Prospectus has been published in electronic form and will shortly be
available on the Company's website at: https://www.med.energy/companydocuments
(https://www.med.energy/companydocuments) .

 

A copy of the Prospectus has also been submitted to the National Storage
Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

Pieter Krügel, MED CEO, commented: "We are delighted that the FCA has
approved our Prospectus, which satisfies the final key condition to the Equity
Fundraise. The MED Board, management and advisors worked around the clock the
past few weeks to get the Prospectus finalised and approved in a very short
timeframe, in order to expedite the completion of the Equity Fundraise. With
all the key conditions to the Equity Fundraise now successfully satisfied, we
are expecting the Equity Fundraise to complete shortly. We are looking forward
to updating the market in this regard over the coming days."

 

Capitalised terms used in this announcement have the same meaning as those
given to them in the 23 May 2025 RNS announcement unless otherwise
defined.

 

Stay up to date with MED's latest news and updates by joining our emailing
list and social media channels, as follows:

 

MED emailing list - https://www.med.energy/contact
(https://www.med.energy/contact)

MED LinkedIn page -
https://uk.linkedin.com/company/mast-energy-developments-plc
(https://uk.linkedin.com/company/mast-energy-developments-plc)

MED X (formerly Twitter) handle - @mastplc

 

 

ENDS

 

This announcement contains inside information for the purposes of the UK
version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of
United Kingdom domestic law by virtue of the European Union (Withdrawal) Act
2018 ('UK MAR'). Upon the publication of this announcement, this inside
information is now considered to be in the public domain.

 

 Pieter Krügel      info@med.energy (mailto:info@med.energy)  Mast Energy           CEO

                                                              Developments PLC
 Jon Belliss        +44 (0)20 7399 9425                       Novum Securities      Corporate Broker
 Guy Wheatley, CFA  +44 (0)74 9398 9014                       Fortified Securities  Corporate Broker

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PSPBGGDRBSGDGUC